Catalyst Wire Dossier Catalyst Wire Dossier

CRN04894

· Crinetics Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CRN04894, covering 2025-04-10 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn) [Phase 2]

See pricing